Funding round
Colossal Seed
Colossal, which works in genome editing and de-extinction services in Austin, raised $15M in a Seed round announced on 1 May 2021, led by Thomas Tull. 1 firm took part. It is Colossal's first venture round on record.
$15M
Amount raised
Not disclosed
Post-money valuation
1
Investors
1 lead
Valuation
What this round says about the price
Colossal did not disclose a valuation in this round. It is Colossal's first venture round on record, in the year it was founded (2021). It is 3.5% of the $425M Colossal has raised in the venture rounds on record. Colossal raised again 10 months later: a Series A round of $60M in Mar 2022. Its next priced round, a Series C in Jan 2025, valued it at $10.20B.
Colossal's funding rounds
Colossal has 4 venture rounds on record and 1 other deal. This one is highlighted.
- Seed this round 1 May 2021, led by Thomas Tull $15M
- Series A 9 Mar 2022, led by At One Ventures $60M
- Grant not a venture round 1 Oct 2022 amount not disclosed
- Series B 31 Jan 2023, led by United States Innovative Technology and Breyer Capital $150M
- Series C 17 Jan 2025, led by TWG Global $200M$10.20B post-money
Investors
Who put money in
Thomas Tull led the round.
Lead investor
- Thomas Tull new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to product development and scaling operations.
- Product development
- Scaling operations
Comparable rounds
How it compares
118 Seed rounds in Biotechnology within a year either side disclosed an amount; the median was $5.0M, and this round was 3.0 times the median. The closest in time, other companies' Seed rounds in Biotechnology:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Biotechnology | 20 May 2021 | $20M | not disclosed | Broadview Ventures |
| Biotechnology | 25 May 2021 | $18M | not disclosed | Vivo Capital |
| Biotechnology | 10 May 2021 | $17M | not disclosed | SV Health Investors and MRL Ventures Fund |
| Biotechnology | 27 May 2021 | $5.7M | not disclosed | Alexandria Venture Investments |
| Biotechnology | 27 May 2021 | $5.0M | not disclosed | Althea Group |
| Biotechnology | 12 May 2021 | undisclosed | not disclosed | not named |
| Biotechnology | 30 Apr 2021 | $17M | not disclosed | not named |
| Biotechnology | 2 Jun 2021 | $13M | not disclosed | Takeda Ventures, Inc. and Dementia Discovery Fund |
Sources
Where this comes from
Reported by 1 source.
Questions
Frequently asked
How much did Colossal raise in its Seed round?
Colossal raised $15M in its Seed round, announced in May 2021.
Who led Colossal's Seed round?
Thomas Tull led it.
What was Colossal's valuation at the Seed round?
It was not disclosed.
How does it compare with other Seed rounds in Biotechnology?
118 Seed rounds in Biotechnology within a year either side disclosed an amount; the median was $5.0M, and this round was 3.0 times the median.
Did Colossal raise again after this round?
Yes: a Series A round in Mar 2022 of $60M.